Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia (2014)
- Authors:
- Lima, Luciene Terezinha de
- Vivona, Douglas
- Bueno, Carolina Tosin
- Hirata, Rosario Dominguez Crespo
- Hirata, Mario Hiroyuki
- Luchessi, André Ducati
- Castro, Fabíola Attié de
- Chauffaille, Maria de Lourdes L. F
- Zanichelli, Maria Aparecida
- Chiattone, Carlos Sérgio
- Hungria, Vania Tietsche de Moraes
- Guerra-Shinohara, Elvira Maria
- USP affiliated authors: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP ; SHINOHARA, ELVIRA MARIA GUERRA - FCF
- Unidades: FCF; FCFRP
- DOI: 10.1007/s12032-014-0851-5
- Subjects: LEUCEMIA MIELOIDE; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Medical Oncology
- ISSN: 1357-0560
- Volume/Número/Paginação/Ano: v. 31, art. 851, p. 1-11, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LIMA, Luciene Terezinha de et al. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, v. 31, p. 1-11, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0851-5. Acesso em: 19 abr. 2024. -
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2014). Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, 31, 1-11. doi:10.1007/s12032-014-0851-5 -
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s12032-014-0851-5 -
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s12032-014-0851-5 - Influência da mutação C677T no gene da enzima metilenotetraidrofolato redutase (MTHFR) nas concentrações de folato, vitamina 'B IND. 12' e homocisteína total em gestantes e seus recém-nascidos
- Influência do polimorfismo C775G no gene da transcobalamina II (TC2) no metabolismo da cobalamina em gestantes
- The methionine synthase (MS) A2756G polymorphism is a genetic determinant of S-adenpsylmethionine (SAM) concentrations in pregnant women
- Evaluation of nutritional and genetic determinants of total homocysteine, methylmalonic acid and S-adenosylmethionine/S-adenosylhomocysteine values in Brazilian childbearing-age women
- Interação entre genótipos para as mutações nos genes HFE e TFR2 e os parâmetros de ferro em doadores de sangue
- HFE gene mutations and iron status of Brazilian blood donors
- SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients
- Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib
- Polimorfismo A1289C do gene da MTHFR e concentrações de folato e vitamina B12 em crianças com defeitos do tubo neural
- Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects
Informações sobre o DOI: 10.1007/s12032-014-0851-5 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
